Page last updated: 2024-08-25

methotrexate and Blood Clot

methotrexate has been researched along with Blood Clot in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19903 (16.67)18.7374
1990's3 (16.67)18.2507
2000's3 (16.67)29.6817
2010's9 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ridker, PM2
Chuang, H; Fanale, M; Fayad, L; Fowler, N; Hagemeister, FB; Kwak, LW; McLaughlin, P; Neelapu, S; Oki, Y; Orlowski, RZ; Ouzounian, ST; Rodriguez, MA; Romaguera, JE; Samaniego, F; Vega, F; Wang, M; Westin, JR; Younes, A1
Lüscher, TF; Ridker, PM1
Philipsen, P; Skiveren, J; Therming, G1
Abrahamsson, J; Asberg, A; Birgens, H; Frandsen, T; Griškevičius, L; Hallböök, H; Helt, LR; Heyman, M; Jónsson, ÓG; Klausen, TW; Palk, K; Pruunsild, K; Quist-Paulsen, P; Schmiegelow, K; Toft, N; Vaitkeviciene, G; Vettenranta, K1
Ortiz, A; Paira, S; Roverano, S1
Ambrosetti, A; Balzarotti, M; Binder, M; Cavalli, F; Cwynarski, K; Deckert, M; Fabbri, A; Ferrari, A; Ferreri, AJ; Finke, J; Fox, CP; Gørløv, JS; Hemmaway, C; Hertenstein, B; Hess, G; Illerhaus, G; Johnson, P; Keller, U; Krause, SW; Levis, A; Linton, KM; Panse, J; Pisani, F; Politi, LS; Ponzoni, M; Pukrop, T; Pulczynski, E; Reni, M; Rosée, PL; Roth, A; Rudà, R; Schmoll, HJ; Schorb, E; Stilgenbauer, S; Torri, V; Tucci, A; Zucca, E1
Çankal, A; Gözmen, S; Irken, G; Ören, H; Tüfekçi, Ö; Vergin, C; Yüksel, F1
Berry, LR; Chan, AK; Paredes, N; Xu, L1
Choudhry, VP; Dixit, A; Kannan, M; Mahapatra, M; Saxena, R1
Colangelo, D; Colavito, P; Colucci, G; Coviello, M; Giotta, F; Maiello, E; Quaranta, M; Rella, C; Schittulli, F1
Oberhoff, C; Schindler, AE; Tauchert, AM; Winkler, UH1
Greywoode, GI; Griffiths, CL; Lewis, SM; Sugden, EM1
Conti, JA; Scher, HI1
Korzun, AH; Norton, L; Perloff, M; Rice, MA; Wall, JG; Weiss, RB; Wood, WC1
Arnold, A; De Pauw, S; Gent, M; Goodyear, MD; Hirsh, J; Hryniuk, W; Levine, MN1
Colon, J; Mayer, M1

Reviews

3 review(s) available for methotrexate and Blood Clot

ArticleYear
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
    Circulation research, 2019, Volume: 124, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; CD40 Antigens; CD40 Ligand; Diabetes Mellitus, Type 2; Disease Models, Animal; Hematopoiesis; Humans; Inflammasomes; Interleukin-18; Interleukin-1beta; Interleukin-6; Methotrexate; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Signal Transduction; Stroke; Thrombosis; Triggering Receptor Expressed on Myeloid Cells-1

2019
Anti-inflammatory therapies for cardiovascular disease.
    European heart journal, 2014, Jul-14, Volume: 35, Issue:27

    Topics: Adaptive Immunity; Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; C-Reactive Protein; Carrier Proteins; Cell Adhesion Molecules; Colchicine; Humans; Hydroxychloroquine; Interleukin-1; Interleukin-6; Leukotriene Antagonists; Lipoproteins, HDL; Methotrexate; NLR Family, Pyrin Domain-Containing 3 Protein; Phospholipase A2 Inhibitors; Receptors, Interleukin-1; Serpins; Signal Transduction; Sirtuins; Thrombosis; Tumor Necrosis Factor-alpha; Vaccination

2014
Focal myositis presenting as pseudothrombophlebitis of the arm.
    Clinical rheumatology, 2016, Volume: 35, Issue:4

    Topics: Antigens, CD20; Arm; Axillary Vein; Biopsy; CD3 Complex; CD8 Antigens; Diagnosis, Differential; Edema; Female; Humans; Lymphocytes; Magnetic Resonance Imaging; Methotrexate; Muscle, Skeletal; Myositis; Prednisone; Thrombosis; Ultrasonography, Doppler; Young Adult

2016

Trials

5 trial(s) available for methotrexate and Blood Clot

ArticleYear
Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
    British journal of haematology, 2013, Volume: 163, Issue:5

    Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Hematologic Diseases; Humans; Kidney Diseases; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Risk; Rituximab; Thrombosis; Vincristine; Young Adult

2013
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
    The Lancet. Haematology, 2016, Volume: 3, Issue:5

    Topics: Acute Kidney Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Comparative Effectiveness Research; Cytarabine; Death, Sudden; Denmark; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Diseases; Germany; Heart Injuries; Hematopoietic Stem Cell Transplantation; Humans; Hyperglycemia; Induction Chemotherapy; Infections; Intraocular Lymphoma; Italy; Kaplan-Meier Estimate; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mucositis; Neurotoxicity Syndromes; Neutropenia; Optic Nerve Neoplasms; Poisoning; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Stroke; Switzerland; Thiotepa; Thrombocytopenia; Thrombosis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; United Kingdom

2016
A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy.
    Breast cancer research and treatment, 1996, Volume: 40, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fibrinolysis; Fluorouracil; Hemostatics; Humans; Methotrexate; Middle Aged; Plasminogen Activator Inhibitor 1; Prothrombin Time; Thrombosis

1996
[Adjuvant CMF chemotherapy in patients with breast cancer--results on blood coagulation and fibrinolysis].
    Zentralblatt fur Gynakologie, 1997, Volume: 119, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fibrinolysis; Fluorouracil; Humans; Longitudinal Studies; Methotrexate; Thrombosis

1997
The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.
    The New England journal of medicine, 1988, Feb-18, Volume: 318, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Prednisone; Pulmonary Embolism; Random Allocation; Tamoxifen; Thrombosis; Time Factors; Vincristine

1988

Other Studies

10 other study(ies) available for methotrexate and Blood Clot

ArticleYear
Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?
    Transactions of the American Clinical and Climatological Association, 2013, Volume: 124

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biomarkers; Cytokines; Female; Folic Acid; Gene Expression Regulation; Humans; Inflammation; Male; Methotrexate; Randomized Controlled Trials as Topic; Thrombosis

2013
Patients with psoriasis have insufficient knowledge of their risk of atherothrombotic disease and metabolic syndrome.
    Clinical and experimental dermatology, 2015, Volume: 40, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Psoriatic; Atherosclerosis; Depressive Disorder; Diabetes Mellitus; Female; Health Knowledge, Attitudes, Practice; Humans; Hypertension; Immunosuppressive Agents; Male; Metabolic Syndrome; Methotrexate; Middle Aged; Obesity; Patient Education as Topic; Psoriasis; Risk Factors; Thrombosis; Young Adult

2015
Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    European journal of haematology, 2016, Volume: 96, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Humans; Infant; Male; Methotrexate; Middle Aged; Osteonecrosis; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Thrombosis; Treatment Outcome; Vincristine

2016
The evaluation of protein Z levels of children with acute lymphoblastic leukaemia during induction therapy.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Proteins; Case-Control Studies; Child; Child, Preschool; Daunorubicin; Female; Hemorrhage; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Thrombosis; Time Factors; Vincristine

2013
The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces.
    British journal of haematology, 2003, Volume: 120, Issue:2

    Topics: alpha-Macroglobulins; Antineoplastic Agents; Antithrombins; Cell Membrane; Doxorubicin; Etoposide; Humans; Methotrexate; Prothrombin; Thrombin; Thromboplastin; Thrombosis; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vincristine

2003
Roles of protein C, protein S, and antithrombin III in acute leukemia.
    American journal of hematology, 2006, Volume: 81, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Asparaginase; Cyclophosphamide; Cytarabine; Disseminated Intravascular Coagulation; Female; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Myocardial Infarction; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prednisone; Protein C; Protein S; Thrombosis; Vincristine

2006
Acute abdomen during adjuvant chemotherapy: superior mesenteric artery thrombosis associated with CMF chemotherapy.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2001, Volume: 13, Issue:6

    Topics: Abdomen, Acute; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Mesenteric Artery, Superior; Mesenteric Vascular Occlusion; Methotrexate; Middle Aged; Thrombosis

2001
Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor. A possible new recombinant granulocyte colony-stimulating factor toxicity.
    Cancer, 1992, Dec-01, Volume: 70, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Granulocyte Colony-Stimulating Factor; Humans; Male; Methotrexate; Recombinant Proteins; Thrombosis; Urinary Bladder Neoplasms; Vinblastine

1992
Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study.
    The American journal of medicine, 1989, Volume: 87, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Breast Neoplasms; Cerebrovascular Disorders; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Methotrexate; Middle Aged; Prednisone; Thiotepa; Thrombosis; Vinblastine; Vincristine

1989
[Intra-arterial chemotherapy in the treatment of pelvic tumors].
    Acta chirurgica Belgica, 1971, Volume: 70, Issue:4

    Topics: Angiography; Antineoplastic Agents; Catheterization; Fluorouracil; Humans; Injections, Intra-Arterial; Methods; Methotrexate; Pelvic Neoplasms; Thrombosis

1971